Medical organisations have criticised Robert F Kennedy Jr's newly constituted CDC vaccine advisory panel as it emerges that ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing ...

At ASCO 2025, ImmunityBio’s chief medical officer, Dr Sandeep Reddy, spoke with pharmaphorum about the importance of FDA Expanded Access authorisation for its Cancer BioShield platform, anchored by ...

9 June 2025: The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of Marketing) to build capability and excellence in marketing in the ...

BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

Nuvation Bio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment ...

The companies have said they will create customised AI models and agents that Novo Nordisk can use for early research and ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.